CDKN2AIP expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.52891066263328E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.01620966986138E-12 |
Normal-vs-Stage2 |
5.14059905754038E-11 |
Normal-vs-Stage3 |
1.62481139653892E-12 |
Normal-vs-Stage4 |
4.44089209850063E-16 |
Stage1-vs-Stage2 |
3.932800E-01 |
Stage1-vs-Stage3 |
2.85339999994694E-06 |
Stage1-vs-Stage4 |
5.69400000000053E-05 |
Stage2-vs-Stage3 |
4.808100E-02 |
Stage2-vs-Stage4 |
5.019600E-02 |
Stage3-vs-Stage4 |
9.195400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.4757973449141E-14 |
Normal-vs-AfricanAmerican |
1.59360002971454E-09 |
Normal-vs-Asian |
3.958400E-02 |
Caucasian-vs-AfricanAmerican |
1.843790E-01 |
Caucasian-vs-Asian |
7.009800E-02 |
AfricanAmerican-vs-Asian |
4.346800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.63735691671718E-12 |
Normal-vs-Female |
3.14193115968919E-12 |
Male-vs-Female |
2.344100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.35440025650757E-10 |
Normal-vs-Age(41-60Yrs) |
2.06434869198802E-12 |
Normal-vs-Age(61-80Yrs) |
2.08721928629529E-14 |
Normal-vs-Age(81-100Yrs) |
1.05929998106546E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.568400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.628600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.990200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.268410E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.990600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.409400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.839000E-04 |
Normal-vs-Grade 2 |
1.49029677487533E-11 |
Normal-vs-Grade 3 |
2.33146835171283E-15 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
2.102000E-01 |
Grade 1-vs-Grade 3 |
1.942510E-03 |
Grade 1-vs-Grade 4 |
4.05380000000344E-05 |
Grade 2-vs-Grade 3 |
4.22069999994612E-06 |
Grade 2-vs-Grade 4 |
6.23380003172969E-09 |
Grade 3-vs-Grade 4 |
2.716600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.13229458931619E-11 |
Normal-vs-ccB subtype |
5.55111512312578E-16 |
ccA subtype-vs-ccB subtype |
1.3891000016919E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.66533453693773E-12 |
Normal-vs-N1 |
1.92500000384399E-08 |
N0-vs-N1 |
2.424400E-01 |
|
|